Manatuck Hill Partners’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-21,500
Closed -$431K 141
2021
Q3
$431K Sell
21,500
-21,500
-50% -$555K 0.15% 88
2021
Q2
$1.33M Hold
43,000
0.4% 59
2021
Q1
$1.1M Hold
43,000
0.37% 59
2020
Q4
$688K Hold
43,000
0.28% 68
2020
Q3
$524K Buy
+43,000
New +$621K 0.24% 80

Other funds holding RNLX

Manatuck Hill Partners's RNLX Position: Q4 2021 in Review

Manatuck Hill Partners sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2021, closing a stake of 21,500 shares — an estimated $431K sold.

Manatuck Hill Partners first reported a position in RNLX in Q3 2020 and held it in 5 quarters. The position peaked at $1.33M in Q2 2021. 33 funds tracked by Wall St. Rank hold RNLX as of Q4 2021.

  • Manatuck Hill Partners reported no remaining Renalytix plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Manatuck Hill Partners sold 21,500 Renalytix plc American Depositary Shares shares in Q4 2021, an estimated $431K.
  • Manatuck Hill Partners first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 5 quarters.
  • Manatuck Hill Partners's Renalytix plc American Depositary Shares position peaked at $1.33M in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2021.

Based on Manatuck Hill Partners's 13F filing for Q4 2021, filed 14 Feb 2022.